OVERVIEW
The global market for genetic testing for preimplantation is expected to reach USD 867.2 million by 2025, rising over the forecast period at a CAGR of 8.98%. The growth of this market is driven largely by the the incidence of infertility across the globe, increasing number of fertility clinics around the world, public-private investments in genetic testing for preimplantation, technological advances in genetic analysis, and the high risk of chromosomal abnormalities in the fetus with the maternal age.
TABLE OF CONTENT
1 Global Preimplantation Genetic Testing Market
1.1 Study Objectives
1.2 Market Definition
1.3 Study Scope
1.3.1 Markets Covered
1.3.2 Geographic Scope
2 RESEARCH METHODOLOGY
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Key Industry Insights
2.1.2.3 Breakdown of Primaries
2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
2.2.2 Top-Down Approach
2.3 Market Breakdown and Data Triangulation
2.4 Research Assumptions
3 Global Preimplantation Genetic Testing Market – Executive Summary
3.1 Market Revenue, Market Size and Key Trends by Company
3.2 Key Trends by type of Application
3.3 Key Trends segmented by Geography
4 Global Preimplantation Genetic Testing Market – Comparative Analysis
4.1 Product Benchmarking – Top 10 companies
4.2 Top 5 Financials Analysis
4.3 Market Value split by Top 10 companies
4.4 Patent Analysis – Top 10 companies
4.5 Pricing Analysis
5 Global Preimplantation Genetic Testing Market – Industry Market Entry Scenario
5.1 Regulatory Framework Overview
5.2 New Business and Ease of Doing business index
5.3 Case studies of successful ventures
5.4 Customer Analysis – Top 10 companies
6 Global Preimplantation Genetic Testing Market – Market Forces
6.1 Introduction
6.2 Market Dynamics
6.2.1 Drivers
6.2.2 Opportunities
6.2.3 Challenges
6.3 Porters Analysis of Market
6.3.1 Bargaining power of suppliers
6.3.2 Bargaining powers of customers
6.3.3 Threat of new entrants
6.3.4 Rivalry among existing players
6.3.5 Threat of substitutes
7 Global Preimplantation Genetic Testing Market – Strategic Analysis
7.1 Value Chain analysis
7.2 Product Life Cycle
7.3 Supplier and distributor analysis (Market share and product dealing strategies)
8 Global Preimplantation Genetic Testing Market – By Product & Service (Market Size – &
million/billion)
8.1 Reagents & Consumables
8.2 Instruments
8.3 Software & Services
9 Global Preimplantation Genetic Testing Market – By Technology
9.1 Next Generation Sequencing (NGS)
9.2 Polymerase Chain Reaction (PCR)
9.3 Fluorescent In-Situ Hybridization (FISH)
9.4 Comparative Genomic Hybridization (CGH)
9.5 Single Nucleotide Polymorphism (SNP)
10 Global Preimplantation Genetic Testing Market – By Procedure Type
10.1 Preimplantation Genetic Screening
10.2 Preimplantation Genetic Diagnosis
11 Global Preimplantation Genetic Testing Market – By Application
11.1 Aneuploidy
11.2 Structural Chromosomal Abnormalities
11.3 Single Gene Disorders
11.4 X-linked Disorders
11.5 HLA Typing
11.6 Gender Identification
12 Global Preimplantation Genetic Testing Market – By End User
12.1 Maternity Centers & Fertility Clinics
12.2 Hospitals, Diagnostic Labs, and Service Providers
12.3 Research Laboratories & Academic Institutes
13 Global Preimplantation Genetic Testing Market – By Geography (Market Size – &
million/billion)
13.1 Introduction
13.2 North America
13.2.1 US
13.2.2 Canada
13.2.3 Mexico
13.3 Europe
13.3.1 U.K
13.3.2 Germany
13.3.3 Italy
13.3.4 France
13.3.5 Spain
13.3.6 Rest of Europe
13.4 Asia-Pacific
13.4.1 China
13.4.2 Japan
13.4.3 India
13.4.4 South Korea
13.4.5 Rest of APAC
13.5 Rest of the World
13.5.1 South America
13.5.2 Middle East
13.5.3 Africa
14 Global Preimplantation Genetic Testing Market – Entropy
14.1 New product launches
14.2 M&A’s, collaborations, JVs and partnerships
15 Global Preimplantation Genetic Testing Market Company Profile (Key Players)
15.1 Market Share, Company Revenue, Products, M&A, Developments
15.2 Illumina, Inc.
15.3 Natera, Inc.
15.4 Rubicon Genomics (A Subsidiary of Takara Bio Usa Holdings, Inc.)
15.5 Oxford Gene Technology
15.6 Yikon Genomics
15.7 Thermo Fisher Scientific Inc.
15.8 Coopersurgical, Inc. (A Subsidiary of the Cooper Companies, Inc.)
15.9 Agilent Technologies, Inc.
15.10 Perkinelmer, Inc.
15.11 ABBott Laboratories
15.12 Company 11 & more
16 Global Preimplantation Genetic Testing Market – Appendix
16.1 Sources
16.2 Abbreviations
